In 2025, the folic acid market was valued at USD 808.5 million. Based on Future Market Insights' analysis, demand for folic acid is estimated to grow to USD 845.9 million in 2026 and USD 1,326.3 million by 2036. FMI projects a CAGR of 4.6% during the forecast period.
Absolute dollar growth of USD 480.4 million over the decade reflects a structural demand base anchored in mandatory fortification policies, maternal nutrition programs, and the expanding nutraceutical supplement market across emerging economies. BASF SE successfully started up major plants at its new Verbund site in Zhanjiang in February 2026, with the Nutrition & Care segment expected to increase earnings significantly, reinforcing the concentration of pharmaceutical-grade folic acid API production among a small number of global chemical producers. [1]
As Dr. Markus Kamieth, CEO of BASF, noted regarding 2025 milestones and 2026 manufacturing outlook, 'We successfully started up the major plants at our new Verbund site in Zhanjiang. Nutrition & Care segments are likely to increase their earnings significantly.' [1]
India leads market growth at 5.9% CAGR through 2036, supported by the National Health Mission's maternal micronutrient supplementation programs and expanding pharmaceutical manufacturing capacity. China grows at 5.3%, driven by API export orientation and domestic nutraceutical demand expansion. The USA grows at 4.2%, with fortification policy reinforcement and the FDA's September 2025 initiation of leucovorin calcium approval for cerebral folate deficiency creating new clinical application demand. [3] UK grows at 2.8%, influenced by the mandatory wheat flour fortification law confirmed for December 2026 implementation. Australia grows at 3.1%, supported by existing mandatory fortification programs. Pharmaceuticals holds 42.6% of application share; tablets dominate form at 53.8%; offline distribution accounts for 71.5% of channel volume.
The folic acid market encompasses the global production, trade, and application of pteroylglutamic acid (folate and its synthetic form folic acid) across pharmaceutical API, nutraceutical supplement, and food fortification end uses. The market includes both synthetic folic acid manufactured through chemical processes and naturally sourced folate derivatives used in pharmaceutical and clinical nutrition formulations. Primary applications span prenatal supplement manufacturing, mandatory wheat flour and staple food fortification, medical nutrition for folate deficiency conditions, and functional food and beverage fortification programs.
The report includes comprehensive global and regional market sizing by volume and value with a 10-year forecast from 2026 to 2036. Segmental analysis covers application type (Pharmaceuticals, Nutraceuticals, Food And Beverages), source (Plants, Animal), form (Tablets, Soft Gels, Lozenges), and distribution channel (Offline, Online). Country-level CAGR analysis encompasses the USA, UK, China, India, and Australia with broader regional coverage. Mandatory fortification program tracking and regulatory compliance timeline analysis are incorporated alongside pricing dynamics.
The scope excludes finished pharmaceutical products such as prenatal multivitamin formulations and prescription folate medications unless the folic acid API component is separately quantified. Naturally occurring folate in unprocessed foods, folinic acid and other folate analogs not used in folic acid fortification applications, and speculative gene therapy or mRNA-based folate metabolism interventions are outside scope. Agricultural fertilizer uses of nitrogen compounds unrelated to nutritional folic acid are excluded.
Increased Fortification of Food Products
There is an increasing trend globally to fortify foods with folic acid. Folate deficiency can be combated effectively when cereals, bread, rice and other staple foods contain folic acid as recommended by governments and health agencies. This has a significant impact on public health since it also increases the demand for folic acid in the food sector.
As consumers become more knowledgeable about the advantages of fortified foods manufacturers prefer to add folic acid into their products so as to meet regulations and address buyer's concerns over a healthy diet.
Rising Popularity of Dietary Supplements
Folic acid is one of the components that drive rapid growth rates in dietary supplement industry globally. The present-day consumer seeks healthier lifestyles hence there is increased demand for tablets containing folic acid as supplements in prenatal care among others related to cardiovascular fitness and even generally healthy living.
Tablets, capsules or gummies make it simpler for users to take them up into their regular habits without much difficulty. For instance, there will always be people who look for ways through which they could improve their health using other means apart from eating healthy and hence, this trend keeps rising.
Advancements in Bioavailability and Delivery Methods
Industry trends show that innovations on how best folate dietary supplements can be consumed are what matters most. As a matter of fact, scientists and researchers are developing folic acid formulations that are being created to enhance its absorption and use in the body.
Among these are more bioavailable forms such as L-methylfolate, chewable tablets and liquid supplements that have been developed with better techniques. Nowadays these changes contribute to making folic acid more effective while at the same time considering different consumer choices thereby facilitating people's nutritional requirements.
The global folic acid landscape has seen significant growth over the past few decades because there is increased awareness of health benefits from it and where it can be used. The industry has grown fast due to increased recognition of the role played by folic acid in preventing neural tube defects during pregnancy thus many governments have ordered for food fortification.
In both developed and developing countries, this regulatory support coupled with an increasing consumer health consciousness has pushed demand for folic acid. In other instances like the pharmaceutical industry, folate deficiency diseases including treatments have made folic acid popular hence driving up its demand in worldwide.
This landscape has also been expanded by the nutraceutical sector through dietary supplements aimed at improving health status among people using them that generally contain folic acid as one of their key ingredients.
On the other hand, there are good indicators that the global folic acid sector will grow in the future. Demand is expected to be driven by a continued shift towards preventive healthcare and an increasing acceptance of dietary supplements.
The efficacy of folic acid as well as its capacity to serve a wider segment of customers could be improved through innovations in product formulations such as the development of more bioavailable forms of folic acid.
Moreover, emerging economies’ growing concern regarding maternal health opens doors for growth. Folic acid consumption is projected to increase with the implementation of food fortification programs and other nutritional interventions targeting malnutrition in certain countries. Finally, market expansion may also be fuelled by improvements in biotechnology and greater use of folic acid in functional foods and beverages.
The folic acid market is moderately fragmented with the presence of both MNCs and regional players. This kind of arrangement leads to diverse products and competitive pricing which are good for customers.
In a fragmented environment, there is no single dominant firm as many small to medium-sized firms operate in it which results into high-level competition and invention. The folic acid sector exhibits these traits, with many companies offering different formulations and delivery methods that satisfy the needs of various consumers.
Alternatively, in a consolidated environment, few large companies dominate leading to less competition but possibly higher prices and less innovation. The huge distribution networks and strong brand recognition held by some big MNCs such as DSM N.V. and BASF SE have made them have significant shares of the folic acid landscape.
Multinational corporations such as Pfizer Inc. or Merck KGaA in the field of folic acid can benefit from their global reach by achieving economies of scale that assure wide product availability across all sectors with consistent quality standards maintained throughout their production process habits. Therefore, they usually engage in extensive research programs that develop highly innovative products or new composition types.
On the other hand, smaller local businesses like Emcure Pharmaceuticals Ltd. from India or Hebei Jiheng Pharmaceutical Co., Ltd. from China concentrate primarily on national landscape, where they possess a deep understanding regarding consumer preferences at regional levels and regulatory policies making them competent enough to challenge established multinationals.
The moderately fragmented nature of the folic acid industry encourages competition and fosters innovation; thus having mixtures of MNCs as well as regional manufacturers enhances its dynamism, allowing wide range price levels with varied goods available to consumers globally.
The following table shows the estimated growth rates of the top industries. The USA and UK are set to exhibit high Folic Acid consumption, recording CAGRs of 4.2% and 2.8%, respectively, through 2036.
.webp "Top Country Growth Comparison Folic Acid Market Cagr (2026 2036)")
| Countries | CAGR 2026 to 2036 |
|---|---|
| USA | 4.2% |
| UK | 2.8% |
| China | 5.3% |
| India | 5.9% |
| Australia | 3.1% |
Widespread awareness of its health benefits and strong regulatory support for folic acid fortification in food products have LED to the United States maintaining high consumption levels of the vitamin. Certain staple foods, including cereals and breads, are mandated by the government to have folic acid added to them as a preventive measure against neural tube defects.
In addition, the USA robust pharmaceutical and nutraceutical sectors ensure a constant supply of dietary supplement capsules containing folic acid.
Folic acid has many health-conscious consumers who also serve as healthcare providers hence contributing to its high consumption rates among different groups in society. The USA landscape is projected to grow at a CAGR of 4.6% from 2026 to 2036 and reach a value of USD 1263.2 million or a value of 26.1% in 2036.
The German market for folic acid has grown over the years and is one of the largest markets in the world due to a health-conscious population and well-established healthcare infrastructure. The German customers prefer preventive healthcare and are well conversant with vitamins as well as supplements such as folic acid. This situation is fostered by Germany's regulatory environment which supports food fortification and high-quality supplementation products.
Additionally, because of these strong pharmaceutical and nutraceutical industries, Germany ensures that there are various brands of folic acid available to its consumers. Hence, through a combination of informed consumer behaviour and industry support, Germany leads in sales of folic acid. The industry is projected to have a world value share of 11.4% in 2036 with a value of USD 808.7 million owing to growth at a forecast CAGR of 3.8% from 2026 to 2036.
Knowing that China has a large population and increased consciousness about personal health is making more and more manufacturers venture into it. This trend is being driven by rising demand for vitamins/supplements including folic acid among Chinese consumers who have become more health conscious. Companies have started introducing other forms of folic acid like fortified foods that suit this trend as evident from their product lines.
To be successful in entering this market, strategic alliances with local firms must be made to comply with the set regulatory standards. Furthermore, creating awareness about the need for vital minerals such as iron can also increase consumer adoption rates thus making China a significant target for these firms. The Chinese landscape is projected to advance with a forecast CAGR of 5.5% from 2026 to 2036 to reach a value of USD 213.3 million in 2036.
| Segment | Food |
|---|---|
| Main segment | Application Type |
| Value Share (2026) | 24.7% |
Currently, there is an increasing use of food fortified with folate as supplements. It is based on the growing number of customers appreciating the benefits accrued from consuming the additional amount of folic acid, particularly during the pregnancy period; while some others may enhance specific health conditions naturally.
As a result, food producers are responding by bolstering different commodities including cereals breads and beverages by fortifying them with folic acid. Consequently, besides boosting the nutrient value in such foods; it offers people an easier alternative for meeting total consumption needs which can lead to better public health effects.
These reasons have LED to Food application gaining a projected value share of 24.7% in 2036 with a value of USD 304. 6 million owing to a forecast CAGR of 6.3%.
| Segment | Tablets |
|---|---|
| Main segment | Form |
| Value Share (2026) | 53.8% |
Tablets are still the most commonly used form to consume folic acid because they are easy to use, have accurate dosage and can be stored easily. They are also widely available and hence can fit in the daily routines of different consumers. Besides this, tablets have a longer life span as compared to other forms thus ensuring that folic acid remains active for a long time.
Moreover, slow-release tablets enhance the absorption and effectiveness. This is evident from the market where tablet sales continue to dominate due to their practicality and reliability when it comes to delivering nutrient requirements. Folic Acid Tablets are projected to grow with a forecast CAGR of 4.4% from 2026 to 2036, which will help it reach a value of USD 1263.2 million or a value share of 53.8% in 2036.
The folic acid market is moderately concentrated in pharmaceutical-grade API supply, with DSM N.V. holding an estimated 27.0% share in 2026 and BASF SE as the second major global producer following completion of its Zhanjiang Verbund site expansions. The competitive field for pharmaceutical and food-grade folic acid API is effectively limited to producers capable of meeting USP, EP, and JP monograph specifications with GMP-compliant manufacturing documentation, restricting meaningful competition to approximately six to eight global API producers. Chinese manufacturers, including Jiangxi Tianxin Pharmaceutical and Hebei Jiheng Pharmaceutical, compete primarily on cost in the food fortification and standard supplement grade segments.
dsm-firmenich's February 2026 announcement of the divestiture of its Animal Nutrition & Health business to CVC Capital Partners for EUR 2.2 billion creates uncertainty for buyers with long-standing supply relationships in the folate and vitamin category. [4] The transaction, classified as assets held for sale, transfers production assets and commercial relationships to a private equity structure, potentially altering supply terms, GMP audit accessibility, and technical support continuity for affected customers. The Sacheon-si Government in South Korea published a tender in February 2026 for folic acid and iron supplements for maternal and child health programs, reflecting the public sector procurement pattern that creates predictable institutional demand across government health programs globally. [5]
Buyer leverage varies significantly by grade. Pharmaceutical-grade buyers with GMP and pharmacopoeia compliance requirements face limited supplier alternatives and moderate-to-low pricing leverage. Food fortification buyers operating under government contracts benefit from volume commitments that enable competitive tendering but face mandatory specification requirements that restrict the supplier pool to certified producers.
Recent Developments
| Metric | Value |
|---|---|
| Quantitative Units | USD 845.9 million (2026) to USD 1,326.3 million (2036), at a CAGR of 4.6% |
| Market Definition | The folic acid market encompasses global production, trade, and application of pteroylglutamic acid and folate derivatives as pharmaceutical API, nutraceutical supplement ingredient, and mandatory food fortification additive across tablet, soft gel, and lozenge delivery forms. |
| Application Type Segmentation | Pharmaceuticals, Nutraceuticals, Food And Beverages |
| Source Segmentation | Plants, Animal |
| Form Segmentation | Tablets, Soft Gels, Lozenges |
| Distribution Channel Segmentation | Offline, Online |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa |
| Countries Covered | United States, United Kingdom, China, India, Australia, Germany, France, Japan, South Korea, Brazil and 40 plus countries |
| Key Companies Profiled | DSM N.V., BASF SE, Jiangxi Tianxin Pharmaceutical Co. Ltd, Emcure Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Medicamen Biotech Ltd., Hebei Jiheng Pharmaceutical Co. Ltd., Hema Pharmaceuticals Pvt. Ltd., Pfizer Inc., Superior Supplement Manufacturing |
| Forecast Period | 2026 to 2036 |
| Approach | Hybrid bottom-up and top-down market modeling validated through primary interviews with pharmaceutical API manufacturers and food fortification program administrators, supported by government regulatory mandate publications and WHO micronutrient guidance |
How large is the demand for Folic Acid in the global market in 2026?
Demand for Folic Acid in the global market is estimated to be valued at USD 845.9 million in 2026.
What will be the market size of Folic Acid by 2036?
Market size for Folic Acid is projected to reach USD 1,326.3 million by 2036.
What is the expected CAGR for the Folic Acid market between 2026 and 2036?
Demand for Folic Acid is expected to grow at a CAGR of 4.6% between 2026 and 2036.
Which application type leads the Folic Acid market in 2026?
Pharmaceuticals holds 42.6% of application share in 2026, anchored by prenatal supplement API demand, mandatory flour fortification programs, and emerging clinical nutrition applications for folate deficiency conditions.
Which form dominates the Folic Acid market?
Tablets dominate at 53.8% of volume in 2026, reflecting established regulatory and consumer preference for tablet-form folic acid dosing in pharmaceutical and supplement contexts.
Which distribution channel holds the largest share?
Offline distribution accounts for 71.5% of channel volume in 2026, consistent with pharmacy and healthcare outlet-dominated purchasing patterns for prenatal and maternal health folic acid products.
What is driving Folic Acid demand in the United Kingdom?
The UK confirmed mandatory folic acid fortification of non-wholemeal wheat flour becoming law in December 2026, creating a new non-discretionary demand pool estimated to prevent approximately 200 neural tube defects annually and reduce NHS expenditure.
What is the growth outlook for Folic Acid in India and China?
India leads at 5.9% CAGR through 2036 driven by National Health Mission maternal nutrition programs and pharmaceutical API capacity expansion. China follows at 5.3% CAGR, supported by API export orientation and domestic nutraceutical market growth.
What is the significance of the BASF Zhanjiang site for Folic Acid supply?
BASF's February 2026 startup of major plants at its Zhanjiang Verbund site is expected to materially increase Nutrition & Care segment output, reinforcing the company's position as a primary global supplier of pharmaceutical-grade folic acid API.
What does this report cover in its scope?
Scope covers folic acid API by application type, form, source, and distribution channel, with regional and country forecasts, mandatory fortification compliance timelines, producer consolidation analysis, and regulatory impact assessment across pharmaceutical and food fortification end uses.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Folic Acid Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
